Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ochuko L. Erukainure, Olubunmi Atolani, Aliyu Muhammad, Sanusi B. Katsayal, Osadolor O. Ebhuoma, Collins U. Ibeji & M. Ahmed Mesaik. (2022) Targeting the initiation and termination codons of SARS-CoV-2 spike protein as possible therapy against COVID-19: the role of novel harpagide 5-O-β-D-glucopyranoside from Clerodendrum volubile P Beauv. (Labiatae). Journal of Biomolecular Structure and Dynamics 40:6, pages 2475-2488.
Read now
Read now
Rajat Mudgal, Sanketkumar Nehul & Shailly Tomar. (2020) Prospects for mucosal vaccine: shutting the door on SARS-CoV-2. Human Vaccines & Immunotherapeutics 16:12, pages 2921-2931.
Read now
Read now
Articles from other publishers (26)
Wataru Ogura, Kouki Ohtsuka, Sachiko Matsuura, Takahiro Okuyama, Satsuki Matsushima, Satoko Yamasaki, Hiroyuki Miyagi, Kumiko Sekiguchi, Hiroaki Ohnishi & Takashi Watanabe. (2022) Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?. Viruses 14:5, pages 956.
Crossref
Crossref
Chulwoo Kim, Jae-Deog Kim & Sang-Uk Seo. (2022) Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2. Journal of Microbiology 60:3, pages 335-346.
Crossref
Crossref
Vladimir BerezinAndrey BogoyavlenskiyMadina AlexyukPavel Alexyuk. (2021) Plant Metabolites as Antiviral Preparations Against Coronaviruses. Journal of Medicinal Food 24:10, pages 1028-1038.
Crossref
Crossref
Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura, Momoko Kurihara, Ryousuke Koike, Otohiro Katsube, Koichi Hagiwara, Seiji Niho, Norihiro Masuda, Takaaki Tanaka & Kumiya Sugiyama. (2021) Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine. Vaccines 9:9, pages 1042.
Crossref
Crossref
Young-Il Kim, Dokyun Kim, Kwang-Min Yu, Hogyu David Seo, Shin-Ae Lee, Mark Anthony B. Casel, Seung-Gyu Jang, Stephanie Kim, WooRam Jung, Chih-Jen Lai, Young Ki Choi & Jae U. Jung. (2021) Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets. mBio 12:2.
Crossref
Crossref
Maram Adel Abdelghany, Sarah Abdullah Gozai Alghamdi & Jehane Ibrahim Eid. 2021. Cell Interaction - Molecular and Immunological Basis for Disease Management. Cell Interaction - Molecular and Immunological Basis for Disease Management.
Yue-Peng Jiang, Xiao-Xuan Zhao, Hui-Qing Lv & Cheng-Ping Wen. (2020) Drug screening and development from the affinity of S protein of new coronavirus with ACE2. European Journal of Clinical Microbiology & Infectious Diseases 40:4, pages 715-723.
Crossref
Crossref
Shan Su, Lanying Du & Shibo Jiang. (2020) Learning from the past: development of safe and effective COVID-19 vaccines. Nature Reviews Microbiology 19:3, pages 211-219.
Crossref
Crossref
Chongyang Shen & Scott A. Bradford. (2021) Why Are Viruses Spiked?. mSphere 6:1.
Crossref
Crossref
Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen, Anthony H. Keeble, Lisa Schimanski, Saira Hussain, Ruth Harvey, Jack W. P. Hayes, Jane C. Edwards, Rebecca K. McLean, Veronica Martini, Miriam Pedrera, Nazia Thakur, Carina Conceicao, Isabelle Dietrich, Holly Shelton, Anna Ludi, Ginette Wilsden, Clare Browning, Adrian K. Zagrajek, Dagmara Bialy, Sushant Bhat, Phoebe Stevenson-Leggett, Philippa Hollinghurst, Matthew Tully, Katy Moffat, Chris Chiu, Ryan Waters, Ashley Gray, Mehreen Azhar, Valerie Mioulet, Joseph Newman, Amin S. Asfor, Alison Burman, Sylvia Crossley, John A. Hammond, Elma Tchilian, Bryan Charleston, Dalan Bailey, Tobias J. Tuthill, Simon P. Graham, Helen M. E. Duyvesteyn, Tomas Malinauskas, Jiandong Huo, Julia A. Tree, Karen R. Buttigieg, Raymond J. Owens, Miles W. Carroll, Rodney S. Daniels, John W. McCauley, David I. Stuart, Kuan-Ying A. Huang, Mark Howarth & Alain R. Townsend. (2021) A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nature Communications 12:1.
Crossref
Crossref
Zhonghua Zhou, Ziyi Yang, Junxian Ou, Hong Zhang, Qiwei Zhang, Ming Dong & Gong Zhang. (2021) Temperature dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome. Computational and Structural Biotechnology Journal 19, pages 161-167.
Crossref
Crossref
Luisa Di Paola, Hamid Hadi-Alijanvand, Xingyu Song, Guang Hu & Alessandro Giuliani. (2020) The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach. Journal of Proteome Research 19:11, pages 4576-4586.
Crossref
Crossref
Daniela S. Oliveira, Nayara I. Medeiros & Juliana A.S. Gomes. (2020) Immune response in COVID-19: What do we currently know?. Microbial Pathogenesis 148, pages 104484.
Crossref
Crossref
Jinkai Zang, Chenjian Gu, Bingjie Zhou, Chao Zhang, Yong Yang, Shiqi Xu, Lulu Bai, Rong Zhang, Qiang Deng, Zhenghong Yuan, Hong Tang, Di Qu, Dimitri Lavillette, Youhua Xie & Zhong Huang. (2020) Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement. Cell Discovery 6:1.
Crossref
Crossref
Anna Illiano, Gabriella Pinto, Chiara Melchiorre, Andrea Carpentieri, Vincenza Faraco & Angela Amoresano. (2020) Protein Glycosylation Investigated by Mass Spectrometry: An Overview. Cells 9:9, pages 1986.
Crossref
Crossref
Nawsad Alam & Matthew K. Higgins. (2020) A spike with which to beat COVID-19?. Nature Reviews Microbiology 18:8, pages 414-414.
Crossref
Crossref
Anam Naz, Fatima Shahid, Tariq Tahir Butt, Faryal Mehwish Awan, Amjad Ali & Arif Malik. (2020) Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach. Frontiers in Immunology 11.
Crossref
Crossref
Hussain Hussain, Aya Fadel, Haidar Alwaeli & Victor Guardiola. (2020) Coronavirus (COVID-19) Fulminant Myopericarditis and Acute Respiratory Distress Syndrome (ARDS) in a Middle-Aged Male Patient. Cureus.
Crossref
Crossref
Shadma Yaqoob, Areena H. Siddiqui, R. Harsvardhan, J. Ahmad, V.K. Srivastava, M.K. Verma, P. Verma & A.N. Singh. (2020) An Overview of Novel Coronavirus SARS-Cov-2 Spanning around the Past, Present and Future Perspectives. Journal of Pure and Applied Microbiology 14:suppl 1, pages 775-788.
Crossref
Crossref
Lili Wang, Jiyan Xu, Yu Kong, Ruiying Liang, Wei Li, Jinyao Li, Jun Lu, Dimiter S. Dimitrov, Fei Yu, Yanling Wu & Tianlei Ying. (2019) Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV. Antibodies 8:4, pages 53.
Crossref
Crossref
Shuai Xia, Lei Yan, Wei Xu, Anurodh Shankar AgrawalAbdullah AlgaissiChien-Te K. TsengQian WangLanying DuWenjie TanIan A. Wilson, Shibo Jiang, Bei Yang & Lu Lu. (2019) A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Science Advances 5:4.
Crossref
Crossref
Khrisdiana Putri, Nadeeka Wawegama, Jagoda Ignjatovic & Amir H. Noormohammadi. (2018) Characterisation of the antigenic epitopes in the subunit 2 haemagglutinin of avian influenza virus H5N1. Archives of Virology 163:8, pages 2199-2212.
Crossref
Crossref
Oliver Ringel, Vincent Vieillard, Patrice Debré, Jutta Eichler, Hildegard Büning & Ursula Dietrich. (2018) The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses. Viruses 10:4, pages 197.
Crossref
Crossref
Naru Zhang, Jian Tang, Lu Lu, Shibo Jiang & Lanying Du. (2015) Receptor-binding domain-based subunit vaccines against MERS-CoV. Virus Research 202, pages 151-159.
Crossref
Crossref
Biao He, Bo-jian Zheng, Qian Wang, Lanying Du, Shibo Jiang & Lu Lu. (2015) Adenovirus-based vaccines against avian-origin H5N1 influenza viruses. Microbes and Infection 17:2, pages 135-141.
Crossref
Crossref
Huan Liu, Wenwen Bi, Qian Wang, Lu Lu & Shibo Jiang. (2015) Receptor Binding Domain Based HIV Vaccines. BioMed Research International 2015, pages 1-9.
Crossref
Crossref